Genetics-informed precision treatment formulation in schizophrenia and bipolar disorder

Genetically informed drug development and repurposing is an attractive prospect for improving patient outcomes in psychiatry; however, the effectiveness of these endeavors is confounded by heterogeneity. We propose an approach that links interventions implicated by disorder-associated genetic risk,...

Descripción completa

Detalles Bibliográficos
Autores principales: Reay, William R., Geaghan, Michael P., Atkins, Joshua R., Carr, Vaughan J., Green, Melissa J., Cairns, Murray J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502060/
https://www.ncbi.nlm.nih.gov/pubmed/36055211
http://dx.doi.org/10.1016/j.ajhg.2022.07.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502060/
https://www.ncbi.nlm.nih.gov/pubmed/36055211
http://dx.doi.org/10.1016/j.ajhg.2022.07.011

Ejemplares similares